Companies: 10,795·Total market cap: $144.5T
WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

WXIBFOTCHealthcare● Active
$4.40
+$0.00(+0.00%)
Market Cap$18.2B
P/E Ratio
52W High$5.606
52W Low$2.85
Overview

WuXi Biologics (Cayman) Inc. (WXIBF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · WXIBF · as of Jun 10, 2026

Key Statistics

EPS (TTM)wxibf eps ttm · wxibf earnings per shareEarnings history
PE Ratio (TTM)wxibf pe ratio ttm · wxibf price to earningsPE Ratio deep dive
Revenue (TTM)wxibf revenue ttm · wxibf annual revenueFull revenue history
Dividend YieldNo Dividenddoes wxibf pay dividends · wxibf dividend yieldDividend history
Shares Outstandingwxibf shares outstanding · wxibf floatShares outstanding history
Next EarningsTBAwxibf earnings date · wxibf next earningsEarnings history

About WuXi Biologics (Cayman) Inc.

CEOZhisheng Chen
IPO DateJan 30, 2018
Employees12,575
CountryCN

WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in Chi…

what is wuxi biologics (cayman) inc. · wxibf stock overview · wuxi biologics (cayman) inc. company profile · who is wuxi biologics (cayman) inc. ceo · wxibf OTC · wuxi biologics (cayman) inc. headquarters · wuxi biologics (cayman) inc. business segments

About Stock Overview & Key Data

WuXi Biologics (Cayman) Inc. (WXIBF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 30, 2018. As of the latest trading session, WXIBF stock price is $4.40, with a market capitalization of $18.2B. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, WuXi Biologics (Cayman) Inc. (WXIBF) stock price is $4.40. The stock is traded on OTC under the ticker symbol WXIBF. The 52-week range is $2.85 – $5.61.

WXIBF stock priceWXIBF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 10, 2026Not investment advice